相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
Jonathan E. Campbell et al.
CELL METABOLISM (2013)
Pioglitazone Acutely Reduces Energy Metabolism and Insulin Secretion in Rats
Julien Lamontagne et al.
DIABETES (2013)
Inhibition of Calcitonin Gene-related Peptide (CGRP) has the Potential to Extend First-phase Insulin Secretion
H. Tanaka et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2013)
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
John B. Buse et al.
LANCET (2013)
PPARγ signaling and metabolism: the good, the bad and the future
Maryam Ahmadian et al.
NATURE MEDICINE (2013)
Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice
Toru Kusakabe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Oral salmon calcitonin attenuates hyperglycaemia and preserves pancreatic beta-cell area and function in Zucker diabetic fatty rats
M. Feigh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Control of energy homeostasis by amylin
Thomas A. Lutz
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
Banting Lecture 2011 Hyperinsulinemia: Cause or Consequence?
Barbara E. Corkey
DIABETES (2012)
Novel GLP-1 receptor agonists for diabetes
Alan J. Garber
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Oral Salmon Calcitonin Improves Fasting and Postprandial Glycemic Control in Lean Healthy Rats
M. Feigh et al.
HORMONE AND METABOLIC RESEARCH (2012)
[D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, augments the effects of orally delivered exenatide and pramlintide acetate on energy balance and glycemic control in insulin-resistant male C57BLK/6-m db/db mice
Matthew C. Leinung et al.
REGULATORY PEPTIDES (2012)
Primer on Pramlintide, an Amylin Analog
Andrea N. Traina et al.
DIABETES EDUCATOR (2011)
A novel oral form of salmon calcitonin improves glucose homeostasis and reduces body weight in diet-induced obese rats
M. Feigh et al.
DIABETES OBESITY & METABOLISM (2011)
Glucoregulatory effects and prolonged duration of action of davalintide: a novel amylinomimetic peptide
C. M. Mack et al.
DIABETES OBESITY & METABOLISM (2011)
Lessons Learned From the Development of Oral Calcitonin: The First Tablet Formulation of a Protein in Phase III Clinical Trials
M. A. Karsdal et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
The Role of Pramlintide for Weight Loss
Kaelen C. Dunican et al.
ANNALS OF PHARMACOTHERAPY (2010)
Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight
C. M. Mack et al.
INTERNATIONAL JOURNAL OF OBESITY (2010)
Surrogate measures of insulin resistance: of rats, mice, and men
Kieren Mather
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Pioglitazone Acutely Reduces Insulin Secretion and Causes Metabolic Deceleration of the Pancreatic β-Cell at Submaximal Glucose Concentrations
Julien Lamontagne et al.
ENDOCRINOLOGY (2009)
Comparison between surrogate indexes of insulin sensitivity and resistance and hyperinsulinemic euglycemic clamp estimates in mice
Sihoon Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats
J. Cacho et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Type 2 diabetes: pathogenesis and treatment
Michael Stumvoll et al.
LANCET (2008)
Central and peripheral administration of amylin induces energy expenditure in anesthetized rats
Toshimasa Osaka et al.
PEPTIDES (2008)
The acute effect of amylin and salmon calcitonin on energy expenditure
Peter Y. Wielinga et al.
PHYSIOLOGY & BEHAVIOR (2007)
The role of α-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications
Beth Elaine Dunning et al.
ENDOCRINE REVIEWS (2007)
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Steven E. Kahn et al.
NATURE (2006)
Islet β cell failure in type 2 diabetes
Marc Prentki et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Vascular actions of calcitonin gene-related peptide and adrenomedullin
SD Brain et al.
PHYSIOLOGICAL REVIEWS (2004)
Islet amyloid polypeptide inhibits glucagon release and exerts a dual action on insulin release from isolated islets
B Åkesson et al.
REGULATORY PEPTIDES (2003)
The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema nucleus of the solitary tract (AP/NTS) lesioned rats
TA Lutz et al.
INTERNATIONAL JOURNAL OF OBESITY (2001)
Selective amylin inhibition of the glucagon response to arginine is extrinsic to the pancreas
RA Silvestre et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2001)
Identification of key components in the irreversibility of salmon calcitonin binding to calcitonin receptors
JM Hilton et al.
JOURNAL OF ENDOCRINOLOGY (2000)
Amylin receptors mediate the anorectic action of salmon calcitonin (sCT)
TA Lutz et al.
PEPTIDES (2000)
分享论文
